COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,254 Articles (22,733 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 421: Articles 4201-4210  | Next

Single-cycle SARS-CoV-2 vaccine elicits high protection and sterilizing immunity in hamsters
Lett, M. J., Otte, F., Hauser, D., Schoen, J., Kipfer, E. T., Hoffmann, D., Halwe, N. J., Ulrich, L., Zhang, Y., Cmiljanovic, V., Wylezich, C., Urda, L., Lang, C., Beer, M., Mittelholzer, C., Klimkait, T.
10.1101/2023.05.17.541127 — Posted: 2023-05-17
Discovery of Novel Allosteric Sites of SARS-CoV-2 Papain-Like Protease (PLpro)
Al Adem, K., Ferreira, J. C., Fadl, S., Villanueva, A. J., Alzyoud, L., Ghattas, M. A., Rabeh, W. M.
10.1101/2023.05.16.540953 — Posted: 2023-05-17
Longitudinal analysis of memory T follicular helper cells and antibody response following CoronaVac vaccination
Zhou, P., Cao, C., Ji, T., Zheng, T., Dai, Y., Liu, M., Jiang, J., Sun, D., Bai, Z., Lu, X., Gong, F.
10.1101/2023.05.16.541033 — Posted: 2023-05-17
SARS-CoV-2 infection leads to Tau pathological signature in neurons
Di Primio, C., Quaranta, P., Mignanelli, M., Siano, G., Bimbati, M., Piazza, C. R., Spezia, P. G., Perrera, P., Basolo, F., Poma, A. M., Costa, M., Pistello, M., Cattaneo, A.
10.1101/2023.05.17.541098 — Posted: 2023-05-17
Immunoglobulin A as a key immunological molecular signature of post-COVID-19 conditions
Sousa, G. F. d., Carpes, R. d. M., Silva, C. A. O., Pereira, M. E. P., Silva, A. C. V. F. d., Coelho, V. A. G. S., Costa, E. P., Mury, F. B., Gestinari, R. d. S., Souza-Menezes, J., da Silva, M. L., Nepomuceno-Silva, J. L., Tanuri, A., Ferreira Junior, O. d. C., Monteiro-de-Barros, C.
10.1101/2023.05.11.23289866 — Posted: 2023-05-16
Predictors of Mortality in Hospitalized Patients with COVID-19: A One-Year Case-Control Study
Camacho-Dominguez, L., Rojas, M., Herran, M., Rodriguez, Y., Beltran, S., Saboya Galindo, P., Aguirre-Correal, N., Espitia, M., Garcia, S., Bejarano, V., Morales-Gonzalez, V., Covaleda-Vargas, J. E., Rodriguez-Jimenez, M., Zapata, E., Monsalve, D. M., Acosta-Ampudia, Y., Anaya, J.-M., Ramirez-Santana, C.
10.1101/2023.05.12.23289918 — Posted: 2023-05-16
Disrupted seasonality and association of COVID-19 with medically attended respiratory syncytial virus infections among young children in the US: January 2010-January 2023
Wang, L., davis, P. B., Berger, N. A., Kaelber, D. C., Volkow, N. D., Xu, R.
10.1101/2023.05.12.23289898 — Posted: 2023-05-16
Regularized COVID-19 Forecast Ensemble Methods
Stephens, A., Mullany, L. C., Kinsey, M., Nicholas, P., Freeman, J., Rainwater-Lovett, K.
10.1101/2023.05.12.23289872 — Posted: 2023-05-16
Absolute and relative excess mortality across demographic and clinical subgroups during the COVID-19 pandemic: an individual-level cohort study from a nationwide healthcare system of US Veterans
Weinberger, D. M., Bhaskaran, K., Korves, C., Lucas, B. P., Columbo, J. A., Vashi, A., Davies, L., Justice, A. C., Rentsch, C. T.
10.1101/2023.05.12.23289900 — Posted: 2023-05-16
Understanding COVID-19 Vaccine Uptake and Hesitancy Among People With HIV in Freetown, Sierra Leone: A Cross-sectional Study
Cummings, P. E., Lakoh, S., Yendewa, S. A., Massaquoi, S. P. E., James, P. B., Sahr, F., Deen, G. F., Gevao, P., Yendewa, G. A.
10.1101/2023.05.11.23289882 — Posted: 2023-05-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).